The focal adhesion kinase (FAK), a consequential downstream constituent of STAT3, exhibited a marked presence in invasive cancer cells, exemplified by RT-4 in our experimental condition, was studied to explore the potential synergistic effects emanating from the perspective of the STAT3 pathway. The gene discussed is STAT3; the disease is cancer.